Newsletter Subject

More Big Pharma fake news

From

alsearsmd.com

Email Address

alsearsmd@send.alsearsmd.com

Sent On

Thu, Oct 3, 2024 07:21 PM

Email Preheader Text

Big Pharma has a cunning new plan to make billions more dollars by telling even more lies - to view

Big Pharma has a cunning new plan to make billions more dollars by telling even more lies - [Click here](1770d7/ct0_0/1/ms?sid=TV2%3AV0QRsljMb) to view this message in your browser | [Click here](1770d7/l-002e/zout?sid=TV2%3AV0QRsljMb) to stop receiving our messages [] [] Al Sears, MD 11905 Southern Blvd. Royal Palm Beach, FL 33411 [] October 3, 2024 [] Reader, Big Pharma has a cunning new plan to make billions more dollars by telling even more lies about their cholesterol-busting statin drugs. [news] Big Pharma plans to make even BIGGER profits by peddling more fake news about its statin drugs. Let me explain… For almost half a century now, they’ve been peddling the lie that statins prevent heart disease. Now they want us to believe the same fake news about Alzheimer’s disease. For decades, doctors – maybe even your own – have convinced the American public how necessary statins are. But multiple major studies disprove it – including the landmark Framingham Heart Study, which found no link between high cholesterol and a raised risk of heart disease.1 Now conventional medicine wants us to believe that these drugs will benefit Alzheimer’s patients… A newly published study by the Karolinska Institute in Stockholm claims that statins can reduce the risk and slow the progress of Alzheimer’s.2 Any evidence supporting this outrageous claim is just as suspicious because the research that supports the use of statins for Alzheimer’s is funded by Big Pharma itself.3 To start with, there is next to no evidence to suggest that high blood cholesterol is a major risk factor for developing any kind of dementia. But the real clue as to why the research was done in the first place can be found at the very bottom of the Swedish study, under “Ethics declarations: Competing interests.” This small section reveals that the study’s design and data analysis were paid for by some of the world’s biggest makers of statins, including Big Pharma giants Pfizer and AstraZeneca. If that’s not evidence of bias, I don’t know what is. I’ve been warning patients against taking statins for as long as I’ve been practicing medicine. And even though this stance has turned me into an outlaw among conventional doctors, I know I’ve saved countless lives – just by getting patients to stop taking these toxic meds. Common statin side effects, like fatigue, muscle pain, and rhabdomyolysis (when muscle cells burst), are enough to tell me you don’t want to go anywhere near these drugs. But the biggest danger is the way statins work. You see, statins don’t just lower LDL, your so-called bad cholesterol. They also reduce your HDL levels… And that dramatically raises your risk of heart disease and heart attacks. As for Alzheimer’s, there is a recent study out of the Keck School of Medicine at the University of Southern California that shows cholesterol particles in cerebrospinal fluid – the fluid found in the tissue surrounding your brain and spinal cord – play a crucial protective role against the condition.4 Lowering your cholesterol to fight Alzheimer’s is a catastrophic idea. The truth is, Big Pharma is desperate to find ways to keep selling these dangerous drugs – primarily because they are so cheap to produce and there are now so many generic versions on the market for heart disease. I advise my patients to throw their statins in the trash right away. There are dozens of safe and effective ways to slow the progress of Alzheimer’s. And I always tell my patients to start the fight against Alzheimer’s by taking the omega-3 fatty acid docosahexaenoic acid, or DHA, the most abundant fatty acid in your brain. DHA is essential for brain health. Studies show it’s a powerful weapon against Alzheimer’s and can also boost memory and cognitive abilities. One clinical trial showed Alzheimer’s patients who took 900 mg of DHA each day experienced almost immediate memory improvement.5,6 The best source of DHA comes from krill and squid oil, because regular fish oil can be loaded with pollutants. To keep brain function strong, take between 600 mg and 1,000 mg of DHA daily. 3 More Supplements To Reboot Your Aging Brain Here are three more supplements I suggest you start today: - Lion’s Mane. Preclinical studies show these white, shaggy mushrooms have neuroprotective properties that can benefit people with Alzheimer’s. Studies reveal that lion’s mane (Hericium erinaceus) influences your brain’s neurogenic and anti-inflammatory pathways. They also nourish brain cells, improve memory and neural connections, reduce inflammation, and boost feelings of well-being.7 You can buy lion’s mane capsules, but I recommend my patients take the dehydrated version – whole or powdered. You can use it regularly to make teas, spice up your coffee, or add it to stews, omelets, and other dishes. You’ll find lion’s mane in health food stores and online. - Creatine: It has been known for years that this nutrient can boost the performance of athletes and bodybuilders – but recent studies also reveal it can prevent Alzheimer’s and other neurodegenerative conditions. Creatine has antioxidant properties and can reduce mental fatigue, protect your brain from neurotoxicity, boost memory, and slow the progress of Alzheimer’s. I recommend taking 3 grams daily.7 - Choline: Choline is the precursor to acetylcholine, a neurotransmitter in your brain responsible for the continual communication between your nerve cells and your brain. As levels of acetylcholine drop, your brain starts to “misfire.” You lose focus, your memory gets fuzzy, and you forget why you went to the grocery store. Eventually, your body “cannibalizes” other sources of choline throughout your body because your brain is so desperate to make acetylcholine. This puts your body at war with itself and sends your cognitive ability into a tailspin. Good food sources for choline include organic, pasture-raised eggs and grass-fed beef liver and meat. But it’s not easy to get enough of what you need through diet alone. So I suggest supplementing with 500 mg of choline. I recommend taking CDP choline, which is short for cytidine 5’-diphosphocholine. This provides an easy-to-absorb form of choline, which the brain starts to use immediately. To Your Good Health, Al Sears, MD, CNS --------------------------------------------------------------- References: - Quinn JF, et al. “Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.” JAMA. 2010 Nov 3;304(17):1903-11. - Yurko-Mauro K, et al. “Beneficial Effects of Docosahexaenoic Acid on Cognition in Age-Related Cognitive Decline.” Alzheimer’s & Dementia, vol. 6, no. 6, Nov. 2010, pp. 456–64. - Kushairi N, et al. “Lion’s Mane Mushroom, Hericium erinaceus (Bull.: Fr.) Pers. Suppresses H2O2-Induced Oxidative Damage and LPS-Induced Inflammation in HT22 Hippocampal Neurons and BV2 Microglia.” Antioxidants (Basel). 2019 Aug; 8(8):261. - Mori K, et al. “Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial.” Phytother Res. 2009 Mar;23(3):367-72. - Quinn JF, et al. “Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.” JAMA. 2010 Nov 3;304(17):1903-11. - Yurko-Mauro K, et al. “Beneficial Effects of Docosahexaenoic Acid on Cognition in Age-Related Cognitive Decline.” Alzheimer’s & Dementia, vol. 6, no. 6, Nov. 2010, pp. 456–64. - Smith A, et al. “Creatine as a Therapeutic Target in Alzheimer’s Disease.” Curr Dev Nutr. 2023 Nov; 7(11): 102011. alsearsmd@send.alsearsmd.com [Preferences | Unsubscribe](1770d7/l-002e/zout?sid=TV2%3AV0QRsljMb) 11905 Southern Blvd., Royal Palm Beach, Florida 33411, United States

Marketing emails from alsearsmd.com

View More
Sent On

09/10/2024

Sent On

07/10/2024

Sent On

04/10/2024

Sent On

02/10/2024

Sent On

01/10/2024

Sent On

30/09/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.